MORE than 17 North American projects, mainly focused on medical instruments, bio-pharmaceuticals and high technology, were presented to Chinese enterprises, funds and high-net-worth individuals at the Global Chinese Financial Forum – Shenzhen Conference 2017 held at Futian Shangri-La Hotel on Thursday.
This year’s event introduced a number of particularly undervalued overseas investment opportunities to investors. These projects not only involve fields that are closely related to quality of life, such as pharmaceuticals, medical instruments, food, nutrients and cosmetics, but also green energy and clean technology that can improve the environment.
Yu Jin’er, deputy secretary general of the Shenzhen Chamber of Investment, said Chinese venture capital institutions have great advantages in terms of quantity, structure and industry governance.
Dr. Li Dahong, chairman and executive director of Hong Kong Grand T G Gold Holdings Ltd., said that Shenzhen investors are more active in the investment market than investors in other first-tier cities, which can largely be attributed to the conveniences provided by the Shenzhen-Hong Kong Stock Connect.
This year’s forum also added a panel discussion, in which guests discussed how to improve China’s overseas direct investment as well as how to source, review and value overseas projects.
The event attracted more than 150 participants, including venture capital companies, banks, securities companies, asset management companies and other investment institutions seeking overseas opportunities.
Source: Shenzhen Daily
